Inventiva S.A. (IVA) Financials

IVA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 210.4 million 221.4 million
March 31, 2025 128.7 million 244.1 million
Dec. 31, 2024 123.9 million 234.9 million
Sept. 30, 2024 43.9 million 132.0 million

IVA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -63.6 million ?
March 31, 2025 -40.7 million 3.9 million
Dec. 31, 2024 -39.2 million 3.7 million
Sept. 30, 2024 -54.1 million ?

IVA Net Income

No data available :(

IVA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 143.9 million 60.8 million -
March 31, 2025 104.5 million - -
Dec. 31, 2024 100.6 million 48.2 million 4.8 million
Sept. 30, 2024 11.6 million - -

IVA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 128.3 million
March 31, 2025 56.2 million
Dec. 31, 2024 99.6 million
Sept. 30, 2024 57.9 million

IVA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 67183 51.0 million 19.6 million -
March 31, 2025 84381 47.7 million 8.2 million 1.5 million
Dec. 31, 2024 81224 45.9 million 9.3 million 1.4 million
Sept. 30, 2024 283977 52.1 million 7.9 million 654817

IVA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 5.2 million 2.0 million
March 31, 2025 7.0 million -569033
Dec. 31, 2024 6.7 million -547742
Sept. 30, 2024 3.0 million 585772

IVA

Price: $4.60

52 week price:
3.16
7.98

Earnings Per Share: -4.36 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: France

Volume: 900

Market Capitalization: 220.9 million

Links: